Experimental Hepatitis C Drug Not Yet Accepted by FDA
Share
Follow Us
The Editors at Hepatitis Central
June 24, 2013
Before starting clinical evaluations, the FDA demands more safety data on Idenix Pharmaceuticals’ new drug.
Idenix says FDA delays hepatitis C drug trials
By The Associated Press
June 20, 2013
NEW YORK (AP) — Idenix Pharmaceuticals Inc. said Thursday the Food and Drug Administration wants more safety data on its experimental hepatitis C drug IDX20963 before it will allow the company to begin human testing.
Continue reading this entire article:
http://www.businessweek.com/ap/2013-06-20/idenix-says-fda-delays-hepatitis-c-drug-trials
